Exact stock surges as changes to Pfizer’s sales agreement a ‘positive,’ analyst sa …

exact stock surges as changes to pfizers sales agreement a positive analyst says

Sumary of Exact stock surges as changes to Pfizer’s sales agreement a ‘positive,’ analyst says:

  • EXAS, +7.94% rallied 8.0% in afternoon trading Wednesday, after the molecular diagnostics company said it taking over the selling of its Cologuard at-home colon cancer screening test from Pfizer Inc. PFE, +0.30%, and said it was discussing with Pfizer “material changes” to their promotion agreement.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close